APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM NEW
Total 13F shares
1,933,445
Share change
-1,475,871
Total reported value
$349,708
Price per share
$0.18
Number of holders
29
Value change
-$275,184
Number of buys
11
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q4 2023

As of 31 Dec 2023, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,933,445 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, SABBY MANAGEMENT, LLC, CITADEL ADVISORS LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, CANTOR FITZGERALD, L. P., and BlackRock Inc.. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.